Home › NDC Lookup › RxCUI directory › RxCUI 1236632

Darunavir 100 MG/ML Oral Suspension [Prezista] — RxCUI 1236632

Name: Darunavir 100 MG/ML Oral Suspension [Prezista] (RxCUI 1236632)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1236632 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1236632

Official nameDarunavir 100 MG/ML Oral Suspension [Prezista]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asPrezista 100 MG/ML Oral Suspension; PREZISTA 100 MG in 1 mL Oral Suspension; Prezista 100 MG per 1 ML Oral Suspension

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)3,800 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Darunavir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

No — darunavir really does need ritonavir to work properly. On its own, your body breaks darunavir down too quickly for it to control HIV. Ritonavir slows that breakdown, which kee...
Why do I have to take ritonavir with my darunavir — can't I just take darunavir alone?
Yes, it really does. Taking darunavir tablets with food increases how much the drug gets into your bloodstream by about 40% compared to taking it on an empty stomach. So the instru...
Does it matter whether I take darunavir with food?

📖 Read our full Darunavir guide →

🕸️ Concept Web — How Darunavir 100 MG/ML Oral Suspension [Prezista] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Darunavir 100 MG/ML Oral Suspension [Prezista] RxCUI 1236632 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Darunavir 460132 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Prezista 643075 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Darunavir Oral Suspension 1236627 SCDF
- Darunavir Oral Liquid Product 1236626 SCDG
- Darunavir Oral Product 1157184 SCDG
- Darunavir Oral Suspension [Prezista] 1236630 SBDF
- Prezista Oral Liquid Product 1236631 SBDG
- Prezista Oral Product 1177658 SBDG
- Oral Suspension 316969 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Darunavir 100 MG/ML Oral Suspension 1236628 SCD
- Darunavir 100 MG/ML 1236625 SCDC
- Darunavir 100 MG/ML [Prezista] 1236629 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Darunavir 100 MG/ML Oral Suspension SCD · 1236628
Darunavir 100 MG/ML SCDC · 1236625
Darunavir Oral Suspension SCDF · 1236627
Darunavir Oral Liquid Product SCDG · 1236626
Darunavir Oral Product SCDG · 1157184

Brand-Name Concepts

Darunavir 100 MG/ML [Prezista] SBDC · 1236629
Darunavir Oral Suspension [Prezista] SBDF · 1236630
Prezista Oral Liquid Product SBDG · 1236631
Prezista Oral Product SBDG · 1177658
Prezista BN · 643075

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 1236632 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
59676-0562-01	60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-562-01)	PREZISTA	Janssen Products LP	2008-03-08
59676-0563-01	480 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-563-01)	PREZISTA	Janssen Products LP	2009-01-14
59676-0564-01	240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-564-01)	PREZISTA	Janssen Products LP	2009-04-27
59676-0565-01	1 BOTTLE, GLASS in 1 CARTON (59676-565-01) / 200 mL in 1 BO...	PREZISTA	Janssen Products LP	2011-12-16
59676-0566-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-566-30)	PREZISTA	Janssen Products LP	2012-11-09

Observed labelers: Janssen Products LP (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.